Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

A Mobile Application to Increase Physical Activity

28 juni 2019 bijgewerkt door: Anna Nordström, Region Västerbotten

A Mobile Application to Increase Physical Activity, a Randomized Controlled Study

A mobile application will be tested in elderly men and women that is randomized to an application (blind-app) that registers physical activity or an application (feedback-app) where participants in addition set goals for physical activity and gets feedback from the application when these goals are achieved. Participants are randomized in permuted blocks of 10 to the blind-app or feedback-app. The primary outcome is increased physical activity. Secondary outcomes include, cardiovascular disease, diabetes, death, dementia, cancer, falls and fractures.

Studie Overzicht

Toestand

Nog niet aan het werven

Gedetailleerde beschrijving

In this randomized controlled study, it will be tested if a mobile application can increase physical activity and reduce the risk of later non-communicable disease.

Participants include individuals that previously have been included in a health survey (Healthy aging initiative, NCT03312439), with a low registered physical activity. Low physical is defined according to WHOs definition, i.e. at least 150 minutes of physical activity per week. Individuals will diabetes will be investigated separately.

Individuals will be excluded that cannot walk for exercise, or if they have diseases that severely affects the ability to exercise. We will also seek participants from the general population to be included with only two inclusion criteria; having a smart phone and at least 18 years of age.

Participants the meet the inclusion criteria will be randomized to an application that only registers physical activity (blind-app) or an application where the participants will set appropriate goals for physical activity and get proper feedback from the app when these goals are reached (feedback-app). Both groups will have individualized information about proper physical activity. Randomization will be made using sealed envelopes in permuted blocks of 10. Randomization will be stratified on year of birth and sex.

The primary outcome will be increased physical activity after 6 months. Secondary outcomes include cardiovascular disease, death, dementia, falls and fractures, diabetes, and improved glucose control in those that already have diabetes. Secondary outcomes also include changes in cardiovascular risk factors, such as blood pressure, blood lipids and obesity. Interaction analysis will be performed to investigate if the effects are different in men and women, based on baseline physical activity and based on age.

Based on the results from the previous health survey the individuals have participated in, a power analyses has been conducted. The participants physical activity were registered using accelerometers. The mean steps taken per week was 48000 with a standard deviation of 22000 steps. With assumption that the feedback-app will increase physical activity by at least 15%, 164 individuals would be needed in each group with an alpha level of 0.05 and a power of 80%. For secondary outcome of cardiovascular disease or death, estimates were based on incidence of these outcomes in 3617 individuals that participated in the health survey. During a mean follow up time of 928 days, 221 participants was diagnosed with cardiovascular disease or died during follow up, and 128 were diagnosed with cardiovascular disease. If assuming that the mobil-application will result in 15% lower risk of these two outcomes in those randomized to the feedback-app, 597 and 1371 individuals would be needed in each group, respectively, with the same follow up time. The effects during follow up will be monitored each year of follow up through patient registers. Follow up time is scheduled to a maximum of 2 years. We estimate that we then would need 895 and 2156 individuals in each group due to the shorter follow up time compared to in the example above.

Studietype

Ingrijpend

Inschrijving (Verwacht)

4000

Fase

  • Niet toepasbaar

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

70 jaar tot 75 jaar (Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Previous participants in healthy aging initiative.

Exclusion Criteria:

  • Not able to walk or previous medical diagnoses that severely limits the possibility to exercise.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Verdrievoudigen

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Active
Participants will be given a mobile-app where they will get feedback from the device based on their physical activity (feedback app)
The active group will be given the feedback app and the control group the blind app
Sham-vergelijker: Control
Participants will be given a mobile-app that does not give feedback back, but the app will register physical activity (blind app).
The active group will be given the feedback app and the control group the blind app

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Increased physical activity as measured by the mobile application in steps per day
Tijdsspanne: 3 years (anticipated)
Increased physical activity in steps per day during the intervention period.
3 years (anticipated)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Incidence of myocardial infarction
Tijdsspanne: 3 years
Diagnoses of myocardial infarction will be tracked using national registers.
3 years
Incidence of diagnosed diabetes
Tijdsspanne: 3 years
Diabetes diagnoses or start of treatment for diabetes will be tracked using national registers.
3 years
Incidence of diagnosed fractures
Tijdsspanne: 3 years
Diagnosed fractures will be tracked using national registers.
3 years
Incidence of diagnosed dementia
Tijdsspanne: 3 years
Diagnosed dementia or start of treatment using dementia drugs will be tracked using national registers.
3 years
Number of participants with high blood pressure
Tijdsspanne: 1 year (anticipated)
Systolic and diastolic blood pressure will be assessed at baseline and later using a sphygmomanometer.
1 year (anticipated)
Number of participants with high blood lipids
Tijdsspanne: 1 year (anticipated)
Blood lipids (cholesterol, LDL-cholesterol, and triglycerides) will be analyzed at baseline and after 6 and 12 months at the department of chemistry.
1 year (anticipated)
Number of participants with high blood glucose
Tijdsspanne: 1 year (anticipated)
Blood glucose will be analysed at the departement of clinical chemistry at baseline and follow up.
1 year (anticipated)
Grade of obesity
Tijdsspanne: 1 year (anticipated)
Obesity will be assessed using a non-elastic measurement tape at the waist
1 year (anticipated)
Body weight
Tijdsspanne: 1 year (anticipated)
Body weight in kilogram measured by a digital scale.
1 year (anticipated)
Incidence of stroke
Tijdsspanne: 3 years
Diagnoses of stroke will be tracked using national registers.
3 years
Incidence of angina pectoris
Tijdsspanne: 3 years
Diagnoses of angina pectoris will be tracked using national registers.
3 years
Incident mortality
Tijdsspanne: 3 years
Death during follow up will be tracked using national registers.
3 years
Number of participants with high glycated hemoglobin
Tijdsspanne: 1 year (anticipated)
Glycated hemoglobin will be measured at baseline and follow up at the Department of clinical chemistry
1 year (anticipated)

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Verwacht)

25 augustus 2019

Primaire voltooiing (Verwacht)

1 januari 2021

Studie voltooiing (Verwacht)

1 januari 2023

Studieregistratiedata

Eerst ingediend

14 februari 2019

Eerst ingediend dat voldeed aan de QC-criteria

19 april 2019

Eerst geplaatst (Werkelijk)

24 april 2019

Updates van studierecords

Laatste update geplaatst (Werkelijk)

2 juli 2019

Laatste update ingediend die voldeed aan QC-criteria

28 juni 2019

Laatst geverifieerd

1 juni 2019

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • VCC_LIFE-5

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

Nee

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Klinische onderzoeken op Physical activity mobile-application

3
Abonneren